Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.
AstraZeneca Pharma India Ltd.
( in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue2.002.002.002.002.00
      
      
INCOME     
Revenue From Operations [Net]1713.291295.531002.97805.60813.56
Other Operating Revenues3.000.000.000.000.00
Total Operating Revenues1716.291295.531002.97805.60813.56
      
Other Income40.6334.8026.1014.7612.84
Total Revenue1756.921330.331029.07820.36826.40
      
EXPENSES     
Cost Of Materials Consumed287.13129.0284.3889.6197.26
Purchase Of Stock-In Trade1008.82499.31324.46207.88194.74
Changes In Inventories Of FG,WIP And Stock-In Trade-332.94-33.77-48.8614.472.95
Employee Benefit Expenses257.44241.45259.10230.21219.54
Finance Costs1.461.200.630.951.09
Depreciation And Amortisation Expenses39.9914.9416.2616.9520.13
Other Expenses241.87275.07218.77177.25163.60
Total Expenses1503.771127.22854.74737.32699.31
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax253.15203.11174.3383.04127.09
      
Exceptional Items-96.7916.43-40.230.000.00
Profit/Loss Before Tax156.36219.54134.1083.04127.09
      
Tax Expenses-Continued Operations     
Current Tax60.1053.5538.3022.6334.83
Deferred Tax-19.92-0.90-3.49-1.19-1.04
Tax For Earlier Years0.445.380.000.000.00
Total Tax Expenses40.6258.0334.8121.4433.79
Profit/Loss After Tax And Before ExtraOrdinary Items115.74161.5199.2961.6093.30
      
Profit/Loss From Continuing Operations115.74161.5199.2961.6093.30
      
Profit/Loss For The Period115.74161.5199.2961.6093.30
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)46.3064.6039.7024.6037.30
Diluted EPS (Rs.)46.3064.6039.7024.6037.30
      
DIVIDEND AND DIVIDEND PERCENTAGE     
Equity Share Dividend60.0040.0020.005.005.00
Equity Dividend Rate (%)1600.001200.00800.00500.00100.00
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue2.00
  
INCOME 
Revenue From Operations [Net]1713.29
Other Operating Revenues3.00
Total Operating Revenues1716.29
Other Income40.63
Total Revenue1756.92
EXPENSES 
Cost Of Materials Consumed287.13
Purchase Of Stock-In Trade1008.82
Changes In Inventories Of FG,WIP And Stock-In Trade-332.94
Employee Benefit Expenses257.44
Finance Costs1.46
Depreciation And Amortisation Expenses39.99
Other Expenses241.87
Total Expenses1503.77
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax253.15
Exceptional Items-96.79
Profit/Loss Before Tax156.36
Tax Expenses-Continued Operations 
Current Tax60.10
Deferred Tax-19.92
Tax For Earlier Years0.44
Total Tax Expenses40.62
Profit/Loss After Tax And Before ExtraOrdinary Items115.74
Profit/Loss From Continuing Operations115.74
Profit/Loss For The Period115.74
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)46.30
Diluted EPS (Rs.)46.30
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend60.00
Equity Dividend Rate (%)1600.00